Literature DB >> 6210468

Immune complexes: characteristics, clinical correlations, and interpretive approaches in the clinical laboratory.

S E Ritzmann, J C Daniels.   

Abstract

Immune-complex-mediated injury is thought to play a role in diseases such as rheumatoid arthritis, systemic lupus erythematosus, serum sickness, various infectious diseases, and malignancies. With increased appreciation of the biological and pathological significance of circulating immune complexes has come efforts to develop appropriate techniques for identifying and measuring them. Common approaches exploit such phenomena as the attachment of complement components to antigen-antibody complexes, the presence of specialized receptors for immune complexes at the surface of cells, and the ability of rheumatoid factor to bind with immune complexes. This variety of assay systems for immune complexes has yielded abstruse results in numerous human pathological conditions. Unfortunately, these results seldom correlate with one another in a given disease. Thus, use of a panel of immune complex assays has been recommended. Indirect consequences of immune complex disease may still be appraised and evaluated with some confidence in clinical medicine: measurements of C3 and C4, cryoglobulins, serum viscosity, and turbidity of serum samples. Measurement of immune complexes may be useful in diagnosis, prognosis, and therapeutic monitoring, but it is the characterization of immune complexes that holds the greatest potential for better understanding of disease mechanisms.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6210468

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Similarity of autoimmune diseases based on the profile of immune complex antigens.

Authors:  Miyako Baba; Kunihiro Ichinose; Mami Tamai; Atsushi Kawakami; Kaname Ohyama
Journal:  Rheumatol Int       Date:  2018-11-13       Impact factor: 2.631

2.  Evidence for anti-tubulin autoantibodies in the form of immune complexes in human sera.

Authors:  F Bernier-Valentin; R Rabilloud; B Rousset
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

3.  Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins.

Authors:  D Goodwin; C Meares; C Diamanti; M McCall; C Lai; F Torti; M McTigue; B Martin
Journal:  Eur J Nucl Med       Date:  1984

4.  Anti-TNF therapy and immunogenicity in inflammatory bowel diseases: a translational approach.

Authors:  Lívia Moreira Genaro; Luís Eduardo Miani Gomes; Ana Paula Menezes de Freitas Franceschini; Hugo Dugolin Ceccato; Rafael Nascimento de Jesus; Amanda Pereira Lima; Cristiane Kibune Nagasako; João José Fagundes; Maria de Lourdes Setsuko Ayrizono; Raquel Franco Leal
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

5.  Detection of complement activation in human serum using C5a-induced chemiluminescence of human granulocytes.

Authors:  A Kapp; F E Maly; E Schöpf
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

6.  What proteins are present in polyethylene glycol precipitates from rheumatic sera?

Authors:  M W Robinson; D G Scott; P A Bacon; K W Walton; J S Coppock; D L Scott
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

7.  Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis.

Authors:  Fauzia Jamal; Pushkar Shivam; Sarita Kumari; Manish Kumar Singh; Abul Hasan Sardar; Selvasankar Murugesan; Shyam Narayan; Anil Kumar Gupta; Krishna Pandey; V N R Das; Vahab Ali; Sanjiva Bimal; Pradeep Das; Shubhankar K Singh
Journal:  PLoS One       Date:  2017-08-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.